Fish oils, coronary heart disease, and the environment

American Journal of Public Health

Volumn 103, Issue 9, 2013, Pages 1568-1576

  Greene, Jonathan ^a   Ashburn, Sarah M ^a   Razzouk, Louai ^a   Smith, Donald A ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FISH OIL;

CORONARY ARTERY DISEASE; ENVIRONMENT; ENVIRONMENTAL PROTECTION; HUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREATMENT OUTCOME;

CONSERVATION OF NATURAL RESOURCES; CORONARY DISEASE; ENVIRONMENT; FISH OILS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84883083369     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2012.300959     Document Type: Article

References (68)

1. Wang C, Harris WS, Chung M, et al. N-3 fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primaryand secondary-prevention studies: a systematic review. Am J Clin Nutr. 2006;84(1):5-17.
2. Bajpai P, Bajpai PK. Eicosapentaenoic acid (EPA) production from microorganisms: a review. J Biotechnol. 1993;30(2):161-183.
3. Huynh MD, Kitts DD. Evaluating nutritional quality of Pacific fish species from fatty acid signatures. Food Chem. 2009;114(3):912-918.
4. Din JN, Harding SA, Valerio CJ, et al. Dietary intervention with oil rich fish reduces platelet-monocyte aggregation in man. Atherosclerosis. 2008;197(1):290-296.
5. Thies F, Garry JM, Yaqoob P, et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet. 2003;361(9356):477-485.
6. Pan M, Cederbaum AI, Zhang YL, Ginsberg HN, Williams KJ, Fisher EA. Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production. J Clin Invest. 2004;113(9):1277-1287.
7. Kang JX, Xiao YF, Leaf A. Free, long-chain, polyunsaturated fatty acids reduce membrane electrical excitability in neonatal rat cardiac myocytes. Proc Natl Acad Sci USA. 1995;92(9):3997-4001.
8. Sinclair HM. The diet of Canadian Indians and Eskimos. Proc Nutr Soc. 1953;12(1):69-82.
9. Bang HO, Dyerberg J, Nielson AB. Plasma lipid and lipoprotein pattern in Greenlandic west-coast Eskimos. Lancet. 1971;1(7710):1143-1145.
10. He K, Song YQ, Daviglus ML, et al. Accumulated evidence on fish consumption and coronary heart disease mortality-a meta-analysis of cohort studies. Circulation. 2004;109(22):2705-2711.
11. Kromhout D, Bosschieter EB, de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med. 1985;312(19):1205-1209.
12. Fraser GE, Sabate J, Beeson WL, Strahan TM. A possible protective effect of nut consumption on risk of coronary heart disease. The Adventist Health Study. Arch Intern Med. 1992;152(7):1416-1424.
13. Ascherio A, Rimm EB, Stampfer MJ, Giovannucci EL, Willett WC. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N Engl J Med. 1995;332(15):977-982.
14. Daviglus ML, Stamler J, Orencia AJ, et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med. 1997;336(15):1046- 1053.
15. Mann JI, Appleby PN, Key TJ, Thorogood M. Dietary determinants of ischaemic heart disease in health conscious individuals. Heart. 1997;78(5):450-455.
16. Albert CM, Hennekens CH, O'Donnell CJ, et al. Fish consumption and risk of sudden cardiac death. JAMA. 1998;279(1):23-28.
17. Oomen CM, Feskens EJ, Rasanen L, et al. Fish consumption and coronary heart disease mortality in Finland, Italy, and The Netherlands. Am J Epidemiol. 2000;151(10):999-1006.
18. Yuan JM, Ross RK, Gao YT, Yu MC. Fish and shellfish consumption in relation to death from myocardial infarction among men in Shanghai, China. Am J Epidemiol. 2001;154(9):809-816.
19. Hu FB, Bronner L, Willett WC, et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA. 2002;287(14):1815-1821.
20. Mozaffarian D, Lemaitre RN, Kuller LH, et al. Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the cardiovascular health study. Circulation. 2003;107(10):1372-1377.
21. Osler M, Andreasen AH, Hoidrup S. No inverse association between fish consumption and risk of death from all-causes, and incidence of coronary heart disease in middle-aged, Danish adults. J Clin Epidemiol. 2003; 56(3):274-279.
22. Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA. 2006;296(15):1885-1899.
23. Iso H, Rexrode KM, Stampfer MJ, et al. Intake of fish and omega-3 fatty acids and risk of stroke in women. JAMA. 2001;285(3):304-312.
24. Kris-Etherton PM, Harris WS, Appel LJ, American Heart Association Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106(21):2747-2757.
25. US Department of Agriculture and US Department of Health and Human Services. Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans, 2010. Available at: http://www.cnpp.usda.gov/DGAs2010- DGACReport.htm. Accessed November 2, 2010.
26. Yokoyama M, Origasa H, Matsuzaki M, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet. 2007; 369(9567):1090-1098.
27. Saito Y, Yokoyama M, Origasa H, et al. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA lipid intervention study (JELIS). Atherosclerosis. 2008;200(1):135-140.
28. Oikawa S, Yokoyama M, Origasa H, et al. Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: sub-analysis of the Japan EPA lipid intervention study (JELIS). Atherosclerosis. 2009;206(2):535-539.
29. The ACCORD Study Group, Ginsberg HN, Elam MB, et al. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med. 2010;362(17):1563-1574. Available at: http://content.nejm.org/cgi/content/ abstract/362/17/1563. Accessed December 5, 2012.
30. ORIGIN Trial Investigators, Bosch J, Gerstein HC, et al. n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med. 2012;367(4): 309-318.
31. Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989;2(8666):757-761.
32. Singh RB, Niaz MA, Sharma JP, Kumar R, Rastogi V, Moshiri M. Randomized, double-blind, placebocontrolled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival-4. Cardiovasc Drugs Ther. 1997;11(3):485-491.
33. [No authors listed.] Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet. 1999;354(9177):447-455.
34. Nilsen DWT, Albrektsen G, Landmark K, Moen S, Aarsland T, Woie L. Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol. Am J Clin Nutr. 2001;74(1):50-56.
35. Burr ML, Ashfield-Watt PAL, Dunstan FDJ, et al. Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr. 2003;57(2): 193-200.
36. GISSI-HF Investigators, Tavazzi L, Maggioni AP, et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9645):1223-1230.
37. Senges J. Omega-3 fatty acids on top of modern therapy after acute Mmyocardial infarction (OMEGA). Paper presented at the American College of Cardiology meeting; March 28-31, 2009; Orlando, FL. Available at: http://www.cardiosource.org/news-media/meetingcoverage/ acc/acc-2009.aspx. Accessed January 27, 2013.
38. Kromhout D, Giltay EJ, Geleijnse JM, Alpha Omega Trial Group. n-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med. 2010;18; 363(21):2015-2026.
39. von Schacky C, Harris WS. Cardiovascular benefits of omega-3 fatty acids. Cardiovasc Res. 2007;73(2):310-315.
40. Marchioli R, Barzi F, Bomba E, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio Della Sopravvivenza Nell'infarto Miocardico (GISSI)-Prevenzione. Circulation. 2002;105(16):1897-1903.
41. Raitt MH, Connor WE, Morris C, et al. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators-a randomized controlled trial. JAMA. 2005;293(23):2884-2891.
42. Leaf A, Albert CM, Josephson M, et al. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation. 2005;112(18):2762-2768.
43. Brouwer IA, Zock PL, Camm AJ, et al. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators-the study on omega-3 fatty acids and ventricular arrhythmia (SOFA) randomized trial. JAMA. 2006;295(22):2613-2619.
44. Brouwer IA, Raitt MH, Dullemeijer C, et al. Effect of fish oil on ventricular tachyarrhythmia in three studies in patients with implanA cardioverter defibrillators. Eur Heart J. 2009;30(7):820-826.
45. Brouwer IA, Heeringa J, Geleijnse JM, Zock PL, Witteman JC. Intake of very long-chain n-3 fatty acids from fish and incidence of atrial fibrillation. The Rotterdam Study. Am Heart J. 2006;151(4):857-862.
46. Mozaffarian D, Psaty BM, Rimm EB, et al. Fish intake and risk of incident atrial fibrillation. Circulation. 2004;110(4):368-373.
47. Calò L, Bianconi L, Colivicchi F, et al. N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol. 2005;45(10):1723-1728.
48. Kowey PR, Reiffel JA, Ellenbogen KA, Naccarelli GV, Pratt CM. Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial. JAMA. 2010;304(21):2363-2372. Available at: http://jama. jamanetwork.com/article.aspx? articleid=186998. Accessed November 14, 2012.
49. Macchia A, Levantesi G, Franzosi MG, et al. Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids. Eur J Heart Fail. 2005;7(5):904-909.
50. Duda MK, Tintinu A, O'Shea KM, Barrows B, Harris WS, Stanley W. Abstract 2371: Dietary supplementation with eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) prevents activation of inflammation and development of left ventricular dysfunction induced by chronic pressure overload. Circulation. 2008;118(18): S711.
51. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res. 2005;96(9):939-949.
52. Nodari S. Effects of n-3 polyunsaturated fatty acids (PUFAs) on left ventricular function and functional capacity in patients with dilated cardiomyopathy. 2011;57(7):870-879.
53. Rauch B, Schiele R, Schneider S, et al. OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation. 2010;122(21):2152-2159.
54. Rauch B, Schiele R, Schneider S, et al. Highly purified omega-3 fatty acids for secondary prevention of sudden cardiac death after myocardial infarction-aims and methods of the OMEGA-study. Cardiovasc Drugs Ther. 2006;20(5):365-375.
55. Vyas AK, Guo H, Moss AJ, et al. Reduction in ventricular tachyarrhythmias with statins in the multicenter automatic defibrillator implantation trial (MADIT)-II. J Am Coll Cardiol. 2006;47(4):769-773.
56. Christensen V, Aiken KA, Villanueva MC. Threats to the ocean: on the role of ecosystem approaches to fisheries. Soc Sci Inf Sci Soc. 2007;46(1):67-86.
57. Watson R, Pauly D. Systematic distortions in world fisheries catch trends. Nature. 2001;414(6863):534-536.
58. The State of World Fisheries and Aquaculture 2006. Rome, Italy: Fisheries and Aquaculture Department, Food and Agriculture Organization of the United Nations; 2007.
59. Naylor RL, Goldburg RJ, Primavera JH, et al. Effect of aquaculture on world fish supplies. Nature. 2000; 405(6790):1017-1024.
60. Jenkins DJ, Sievenpiper JL, Pauly D, Sumaila UR, Kendall CW, Mowat FM. Are dietary recommendations for the use of fish oils sustainable? CMAJ. 2009;180(6): 633-637.
61. Pauly D, Alder J, Bennett E, Christensen V, Tyedmers P, Watson R. The future for fisheries. Science. 2003;302(5649):1359-1361.
62. Costello C, Gaines SD, Lynham J. Can catch shares prevent fisheries collapse? Science. 2008;321(5896): 1678-1681.
63. Worm B, Barbier EB, Beaumont N, et al. Impacts of biodiversity loss on ocean ecosystem services. Science. 2006;314(5800):787-790.
64. US Department of Agriculture, Agricultural Research Service. Nutrient data laboratory. Available at: http://www.ars.usda.gov/nutrientdata. Accessed November 11, 2010.
65. Institute of Medicine. Seafood Choices. Washington, DC: National Academies Press; 2006.
66. Ford R. Norwegian salmon and trout farming. Mar Fish Rev. 1984;46(3):44-47.
67. Omacor capsules new drug application 21-654. Center for Drug Evaluation and Research approval package for application 21-654. Available at: http:// www.accessdata.fda.gov/drugsatfda-docs/nda/2004/ 21-654-Omacor-Chemr.pdf. Accessed November 11, 2010.
68. Kumari P, Kumar M, Gupta V, Reddy CRK, Jha B. Tropical marine macroalgae as potential sources of nutritionally important PUFAs. Food Chem. 2010;120(3): 749-757.